Skip to main content

Advertisement

Log in

Nationwide analysis of adult hospitalizations with hemophagocytic lymphohistiocytosis and systemic lupus erythematosus

  • ORIGINAL ARTICLE
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction

Hemophagocytic lymphohistiocytosis (HLH) is a well-recognized complication of systemic lupus erythematosus (SLE). This study aims to characterize HLH with and without SLE in the US adult inpatient population.

Methods

We performed a retrospective study of HLH with and without SLE from the 2016–2019 National Inpatient Sample (NIS) database. We described the demographic characteristics of HLH with and without SLE. Multivariable analysis was performed to calculate odds ratios (OR) for in-hospital death.

Results

A total of 8690 hospitalizations had HLH. Of those 605 (7%) had SLE, and 8085 (93%) did not have SLE. Relative to the non-SLE group, the SLE group was younger, had more females, less whites, more African Americans, more Hispanics, and more Asian/Pacific Islanders. Over 60% of HLH with or without SLE had a concurrent infection. Sixty (9.9%) of HLH hospitalizations with SLE died compared to 1735 (21.5%) of those without SLE. Among HLH hospitalizations, multivariable analysis showed that age (OR 1.02; 95% C.I. 1.016–1.031), Charlson Comorbidity Index (OR 1.15; 95% C.I. 1.091–1.213), infections (OR 3.35; 95% C.I. 2.467–4.557), and leukemia/lymphoma (OR 1.46; 95% C.I. 1.112–1.905) had higher odds of in-hospital death. SLE did not increase the odds of death.

Conclusions

Inpatients with both HLH and SLE were younger, had a higher proportion of racial/ethnic minorities, and were predominately female. One out of every 10 hospitalizations for HLH ended in death but SLE itself was not an independent risk factor for death. Concurrent infection was the variable most associated with HLH death.

Key Points

HLH and SLE group were younger and had higher proportions of female and racial/ethnic minorities.

SLE was not an independent risk factor for death in HLH patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Lorenz G, Schul L, Schraml F et al (2020) Adult macrophage activation syndrome haemophagocytic lymphohistiocytosis: “of plasma exchange and immunosuppressive escalation strategies” - a single centre reflection. Lupus 29:324–333. https://doi.org/10.1177/0961203320901594

    Article  CAS  PubMed  Google Scholar 

  2. Borgia RE, Gerstein M, Levy DM et al (2018) Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ) 70:616–624. https://doi.org/10.1002/art.40417

    Article  CAS  Google Scholar 

  3. Dall’Ara F, Cavazzana I, Frassi M et al (2018) Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center. Reumatismo 70:100–105. https://doi.org/10.4081/reumatismo.2018.1023

    Article  PubMed  Google Scholar 

  4. Henter JI, Aricò M, Egeler RM et al (1997) HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 28:342–347. https://doi.org/10.1002/(sici)1096-911x(199705)28:5%3c342::aid-mpo3%3e3.0.co;2-h

    Article  CAS  PubMed  Google Scholar 

  5. Patel AR, Desai PV, Banskota SU et al (2022) Hemophagocytic lymphohistiocytosis hospitalizations in adults and its association with rheumatologic diseases: data from nationwide inpatient sample. J Clin Rheumatol 28:e171–e174. https://doi.org/10.1097/RHU.0000000000001670

    Article  PubMed  Google Scholar 

  6. Huang L-W, Wei JC-C, Chen D-Y et al (2022) Bidirectional association between systemic lupus erythematosus and macrophage activation syndrome: a nationwide population-based study. Rheumatology (Oxford) 61:1123–1132. https://doi.org/10.1093/rheumatology/keab502

    Article  PubMed  Google Scholar 

  7. Gavand P-E, Serio I, Arnaud L et al (2017) Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients. Autoimmun Rev 16:743–749. https://doi.org/10.1016/j.autrev.2017.05.010

    Article  CAS  PubMed  Google Scholar 

  8. Li NL, Kang R, Ardoin SP, Ayoub I (2021) Hemophagocytic lymphohistiocytosis, a rare presentation in lupus nephritis. Kidney Int Rep 6:842–845

    Article  PubMed  Google Scholar 

  9. Kumakura S, Murakawa Y (2014) Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol (Hoboken, NJ) 66:2297–2307. https://doi.org/10.1002/art.38672

    Article  Google Scholar 

  10. Aziz A, Castaneda EE, Ahmad N et al (2021) Exploring macrophage activation syndrome secondary to systemic lupus erythematosus in adults: a systematic review of the literature. Cureus 13:e18822. https://doi.org/10.7759/cureus.18822

    Article  PubMed  PubMed Central  Google Scholar 

  11. Parodi A, Davì S, Pringe AB et al (2009) Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 60:3388–3399. https://doi.org/10.1002/art.24883

    Article  CAS  PubMed  Google Scholar 

  12. Wong KF, Hui PK, Chan JK et al (1991) The acute lupus hemophagocytic syndrome. Ann Intern Med 114:387–390. https://doi.org/10.7326/0003-4819-114-5-387

    Article  CAS  PubMed  Google Scholar 

  13. Fukaya S, Yasuda S, Hashimoto T et al (2008) Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 47:1686–1691. https://doi.org/10.1093/rheumatology/ken342

    Article  CAS  PubMed  Google Scholar 

  14. Naveen R, Jain A, Muhammed H et al (2021) Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities. Rheumatol Int 41:625–631. https://doi.org/10.1007/s00296-020-04763-6

    Article  CAS  PubMed  Google Scholar 

  15. Ramos-Casals M, Brito-Zerón P, López-Guillermo A et al (2014) Adult haemophagocytic syndrome. Lancet (London, England) 383:1503–1516. https://doi.org/10.1016/S0140-6736(13)61048-X

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all participants in this study for their joint contribution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Emilia Romero Noboa.

Ethics declarations

Disclosures

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noboa, M.E.R., Lopez-Arevalo, H., Patel, A.R. et al. Nationwide analysis of adult hospitalizations with hemophagocytic lymphohistiocytosis and systemic lupus erythematosus. Clin Rheumatol 42, 2091–2095 (2023). https://doi.org/10.1007/s10067-023-06594-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06594-9

Keywords

Navigation